loader

World Tenders & Procurement Opportunities

Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens has been published on Bidding Source portal dated 25 Mar 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
Contract notice
2019/S 058-133397
Germany
Germany-Potsdam
25 Mar 2019
30 Apr 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

392472 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient combination of olodaterol and tiotropium bromide (ATC code: R03AL06). Germany 394812 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient sulfasalazine (ATC code: M01CX02). Germany 394382 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient fusidic acid (ATC code: D06AX01). Germany 394434 - Germany – Pharmaceutical products – Medicinal products containing the active ingredient lanthanum(III) carbonate (ATC: V03AE03 - in the dosage form of chewable tablets) Germany 394732 - Germany – Pharmaceutical products – Drug rebate agreements from 01.08.2026 for various active ingredients within the framework of an open-house procedure Germany 385850 - Germany – Pharmaceutical products – Open House Biologics Discount Agreements 2026-24 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml) Germany 386710 - Germany – Pharmaceutical products – Open-House biologics discount contracts 2025-25 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml) Germany 385341 - Germany – Pharmaceutical products – Medicinal products containing the active ingredient ustekinumab (ATC: L04AC05) Germany 387146 - Germany – Pharmaceutical products – Open House Biologics Discount Agreements 2026-23 - Darbepoetin alfa Germany 385290 - Germany – Pharmaceutical products – Drug containing the active ingredient denosumab (ATC: M05BX04) Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans